ABSTRACT
OBJECTIVE: To present a patient with brainstem abscess treated by microsurgical resection. CASE PRESENTATION: A 53-years-old female patient admitted to the neurosurgical department in a severe condition with symptoms of intracranial hypertension, hyperthermia, general infectious signs and laboratory manifestations of infectious process. Contrast-enhanced MRI revealed a large brainstem lesion (abscess). Retrosigmoid craniotomy with total microsurgical resection of the abscess was performed. External ventricular drainage was incerted on the second postoperative day due to progressive hydrocephalus with clinical deterioration, it was removed in 8 days. Slow positive dynamics was observed in postoperative period. The patient was discharged in 2 weeks after surgery. CONCLUSION: There are no established algorithm for the treatment of brainstem abscesses. Therapeutic approach is advisable for small abscesses. There are 2 neurosurgical options for this lesion: stereotactic drainage and microsurgical resection with or without external ventricular drainage. Treatment strategy depends on location and size of abscess, as well as clinical state of the patient.
Subject(s)
Brain Abscess , Brain Abscess/diagnostic imaging , Brain Abscess/surgery , Brain Stem/diagnostic imaging , Brain Stem/surgery , Craniotomy , Drainage , Female , Humans , Magnetic Resonance Imaging , Middle AgedABSTRACT
The last decade has seen active development of minimally invasive (endovenous) methods of surgical removal of lower limb varicose veins (LLVV); however, the problem of increasing efficacy of these methods and improving long-term results still remains of current importance. The authors of this work propose a method of ultrasound ablation of subcutaneous veins of lower extremities. Our experimental study was aimed at determining the pattern of venous wall damage after ultrasound exposure. Samples of segments of the trunk of the great saphenous vein (GSV) were divided into 5 groups: group 1 - the control group, group 2 - treatment with a sclerosant in the amount of 0.3 ml for 30 s, group 3 - treatment with ultrasound at a frequency of 26 kHz and amplitude 40 µm and 0.3-ml sclerosant for 30 s, group 4 - exposure to ultrasound at a frequency of 26 kHz and amplitude 40 µm and 0.3-ml sclerosant for 60 s, group 5 samples were exposed to ultrasound at 26 kHz and amplitude of 40 µm for 60 s. The results of analysing the histological sections of the samples of the 2nd and 3rd groups demonstrated that the degree of alteration in the GSV wall on combined exposure to ultrasound and a sclerosant was 4.5-fold higher as compared with treatment with a sclerosant solution alone. During ultrasound exposure, the maximum temperature of the venous wall of group 5 samples was by 20 °C higher than in samples of group 4. Analysing the histological sections demonstrated a similar pattern of structural alterations of the samples of group 4 and 5, thus suggesting a possibility of controlling the temperature of the venous wall during ultrasound ablation without changing quality of structural lesions. The obtained findings showed a possibility of initiating irreversible dystrophic alterations in the venous wall on exposure to ultrasound by means of combining the mechanisms of chemical, mechanical, and thermal ablation.
Subject(s)
Catheter Ablation , Laser Therapy , Varicose Veins , Venous Insufficiency , Humans , Lower Extremity , Saphenous Vein , Sclerosing Solutions , Treatment Outcome , Varicose Veins/therapyABSTRACT
Liver resection remains the method of choice for treatment of colorectal liver metastases with good long-term results. Regional lymph nodes involvement is significant negative prognostic factor. Moreover, it has been considered as a contraindication for liver resection for a long time. The role of lymphadenectomy remains controversial. Current state of this problem is reviewed in the article. Liver regional lymph nodes involvement takes place in 10-20% of cases. PET/CT is the most sensitive method of preoperative diagnosis. Involvement of liver regional lymph nodes is currently not absolute contraindication for liver resection. Routine lymphadenectomy does not make sense, and, perhaps, is justified only within scientific trials for more accurate disease staging. Indications for lymphadenectomy are suspicious changes of lymph nodes revealed by preoperative visualization methods or by intraoperative exploration. Modern chemotherapy regimens allow to reconsider the prognostic importance of liver regional lymph node metastases and to extend indications for liver resections.
Subject(s)
Colorectal Neoplasms/secondary , Liver Neoplasms/therapy , Lymph Node Excision , Lymph Nodes/pathology , Antineoplastic Agents/therapeutic use , Colorectal Neoplasms/diagnostic imaging , Colorectal Neoplasms/pathology , Colorectal Neoplasms/therapy , Hepatectomy , Humans , Liver Neoplasms/diagnostic imaging , Liver Neoplasms/pathology , Liver Neoplasms/surgery , Lymph Nodes/diagnostic imaging , Lymphatic Metastasis , Neoplasm Staging , Positron Emission Tomography Computed Tomography , PrognosisABSTRACT
The paper describes a case of chromophobe renal cell carcinoma growing into the muscular layer of the descending colon and with metastases in 4 lymph nodes of paranephral tissue in a 66-year-old woman. The tumor had a zonal structure with an alternation of epithelioid and sarcomatoid structural sites and with the signs of grades I, II and III according to the grading system by Paner and et al. (2010). The sarcomatoid renal component occupied about 70.0% of the tumor. There was a pronounced immunohistochemical reaction with VEGF-A (5 scores), a high Ki-67 proliferation index (70%), and a large number of tumor cells with nuclear p53 expression (85%) in the areas with minimal differentiation and sarcomatoid elements (Grade III). These signs can serve as criteria for the aggressive behavior of the tumor. A large volume of the sarcomatoid carcinoma component and a strong reaction with VEGF-A are indications for targeted therapy with anti-VEGF drugs.
Subject(s)
Carcinoma, Renal Cell/genetics , Ki-67 Antigen/genetics , Tumor Suppressor Protein p53/genetics , Vascular Endothelial Growth Factor A/genetics , Aged , Carcinoma, Renal Cell/diagnosis , Carcinoma, Renal Cell/pathology , Carcinoma, Renal Cell/therapy , Cell Differentiation/genetics , Cell Proliferation/genetics , Female , Gene Expression Regulation, Neoplastic , Humans , Lymph Nodes/metabolism , Lymph Nodes/pathology , Lymphatic Metastasis , Molecular Targeted TherapyABSTRACT
The paper describes a case of solitary epithelioid hemangioendothelioma concurrent with nodular parenchymal AL amyloidosis of the lung and Rosai-Dorfman disease in a 70-year-old woman. The core of the tumor was represented by bone tissue with dendriform ossification, as well as by amyloid that showed green apple birefringence at polarized light microscopy. The peripheral portions of the tumor and the myxohyaline stroma exhibited slit-like structures, epithelioid and fusiform cells with small cytoplasmic vacuoles. These cells expressed CD31, CD34, factor VIII, and cytokeratins 7 and 18. The Ki-67 proliferation index was 10%. S100- and CD68-positive histiocytes with the phenomenon of emperipolesis were revealed in the tumor and in the lymph nodes of the mediastinum and lung hilum. There was a positive reaction to immunoglobulin lambda light chains in the lymphocytic infiltration around amyloid clumps. The frequency of epithelioid hemangioendothelioma was less than 1 case per million people annually. We found only one case of its concurrence with pulmonary amyloidosis in the English-language literature. No relationship could be revealed between this tumor and Rosai-Dorfman disease.
Subject(s)
Amyloidosis , Hemangioendothelioma, Epithelioid , Histiocytosis, Sinus , Aged , Amyloidosis/complications , Amyloidosis/diagnosis , Cytokines/analysis , Female , Hemangioendothelioma, Epithelioid/complications , Hemangioendothelioma, Epithelioid/diagnosis , Histiocytes , Histiocytosis, Sinus/complications , Histiocytosis, Sinus/diagnosis , Humans , Lymph NodesABSTRACT
The paper describes cases of disseminated small-cell carcinoma after kidney transplantation from a deceased donor to two patients. Microscopic examination showed that the kidney graft tumor consisted of tightly packed small rounded cells with hyperchromatic nuclei and a narrow cytoplasmic rim with invisible nucleoli. The mitotic index was 25-40/2 mm2. Azzopardi's phenomenon and crush artifact were detected in the tumor. Giant cell and large cell components were 30-40% of the area of sections. Immunohistochemical examination revealed the expression of synaptophysin, chromogranin A, CD56, TTF-1, HMWK, СÐ7, СÐ18, and Ki-67 (80% of tumor cells). Histological findings and immunophenotype in both cases led to the conclusion about combined small cell carcinoma with renal graft involvement. Both patients died from tumor dissemination 9 and 11 months after transplantations. In reviewing the literature, the authors found only one such observation.
Subject(s)
Carcinoma, Small Cell/pathology , Kidney Neoplasms/pathology , Kidney Transplantation/adverse effects , Adult , Carcinoma, Small Cell/epidemiology , Carcinoma, Small Cell/etiology , Carcinoma, Small Cell/mortality , Female , Humans , Kidney Neoplasms/epidemiology , Kidney Neoplasms/etiology , Kidney Neoplasms/mortality , Kidney Transplantation/mortality , Male , Middle Aged , Tissue DonorsABSTRACT
The paper describes a case of eosinophilic granuloma of the parietal bone in a 32-year-old man. Histological examination revealed a large number of bean-shaped Langerhans cell histiocytes with lobed nuclei and nuclear grooves. The histiocytes alternated with the foci of obvious eosinophilic infiltration and with eosinophilic microabscesses. There were osteoclast-like multinucleated giant cells, bone resorption, and numerous bone rods covered with osteoblast chains. The histiocytes expressed CD1α, langerin, CD68, S100, and p53 (in 90.0% of the tumor cells). The Ki-67 proliferation index was 18.0%. A molecular genetic study identified BRAFV600E mutation (nucleotide substitution s.1799 T>A (p.V600E) in the heterozygous state). Clinical and morphological data and the results of molecular genetic studies led to the conclusion that there was eosinophilic granuloma of the right parietal bone (the unifocal form of Langerhans cell histiocytosis (LCH), type I, group A1, with the monoossal nature of lesion and with BRAFV600E mutation). In adults, this disease is extremely rare (2-5 cases of LCH per million people, bone loss in the fourth decade of life in 2.5% of the patients).
Subject(s)
Eosinophilic Granuloma/pathology , Histiocytosis, Langerhans-Cell/pathology , Parietal Bone/pathology , Proto-Oncogene Proteins B-raf/genetics , Adult , Eosinophilic Granuloma/diagnosis , Eosinophilic Granuloma/diagnostic imaging , Eosinophilic Granuloma/genetics , Histiocytes , Histiocytosis, Langerhans-Cell/diagnosis , Histiocytosis, Langerhans-Cell/diagnostic imaging , Histiocytosis, Langerhans-Cell/genetics , Humans , Immunohistochemistry , Male , Mutation , Parietal Bone/diagnostic imagingSubject(s)
Adenocarcinoma , Gastrectomy/methods , Hepatectomy/methods , Liver Neoplasms , Lung Neoplasms , Pneumonectomy/methods , Stomach Neoplasms , Adenocarcinoma/pathology , Adenocarcinoma/physiopathology , Adenocarcinoma/surgery , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Humans , Liver Neoplasms/drug therapy , Liver Neoplasms/pathology , Liver Neoplasms/secondary , Liver Neoplasms/surgery , Lung Neoplasms/drug therapy , Lung Neoplasms/pathology , Lung Neoplasms/secondary , Lung Neoplasms/surgery , Male , Middle Aged , Neoplasm Staging , Stomach Neoplasms/pathology , Stomach Neoplasms/physiopathology , Stomach Neoplasms/surgery , Treatment OutcomeABSTRACT
To paper describes a case of paucicellular anaplastic cancer in the presence of tall cell variant papillary thyroid carcinoma. Microscopic examination showed that the differentiated component of the tumor was composed of papillary structures with tall cells, the height of which exceeded 3-4 times the width. Its anaplastic component consisted of fibrous tissue with occasional spindle-shaped cells and focal lymphocytic infiltration to the extent of 70%. The spindle-shaped cells expressed cytokeratins, ß-catenin, p53, and vimentin. The tumor cells and lymphocytes showed an association with Epstein-Barr virus. Molecular genetic study of the tumor revealed the following mutations: BRAF p.Val600Glu (p.V600e was), HRAS p.His27His (p.H27H), PIK3CA p.Glu545Lys (p.E545K), TP53 p.Arg248Gln (p.R248Q).
Subject(s)
Carcinoma, Papillary/pathology , Proto-Oncogene Proteins B-raf/genetics , Thyroid Carcinoma, Anaplastic/pathology , Thyroid Neoplasms/pathology , Carcinoma, Papillary/diagnostic imaging , Carcinoma, Papillary/genetics , Female , Humans , Middle Aged , Mutation , Thyroid Cancer, Papillary , Thyroid Carcinoma, Anaplastic/diagnostic imaging , Thyroid Carcinoma, Anaplastic/genetics , Thyroid Neoplasms/diagnostic imaging , Thyroid Neoplasms/genetics , Tomography, X-Ray ComputedABSTRACT
The present article was designed to report the results of the analysis of the cases of traumatic and spontaneous ruptures of the organs affected by the tumours based on the original observations and the literature data. It is shown that the probability of the tumour rupture depends on its histological type, localization, the size, and the distance from the capsule of the affected organ, the degree of involvement of the major blood vessels, the severity of the necrotic changes, the presence of cysts in the neoplasm, and the regimens of radio- and chemotherapy. Moreover, the rupture can be facilitated by anticoagulation therapy, intake or oral contraceptives, pregnancy, concomitant diseases, alcoholic intoxication, splenomegaly, and hypocoagulation resulting from dissemination of the neoplastic process or the metastatic lesions of the liver. Even a minimal injury to the skin can provoke the tumour rupture associated with the fatal hemorrhage. A delayed rupture within a few hours or days is possible.
Subject(s)
Hemorrhage , Neoplasms/complications , Risk Assessment/methods , Rupture, Spontaneous/diagnosis , Rupture/diagnosis , Cause of Death , Forensic Medicine , Hemorrhage/etiology , Hemorrhage/mortality , Humans , Neoplasms/classification , Neoplasms/pathology , Risk Factors , Rupture/etiology , Rupture, Spontaneous/etiologyABSTRACT
AIM: To investigate clinical, diagnostic and surgical aspects of papillary fibroelastomas of the heart. MATERIAL AND METHODS: Clinical, diagnostic and surgical aspects of papillary fibroelastomas of the heart were analyzed in 12 patients. RESULTS: Diagnosis was obtained using two-dimensional echocardiography and transesophageal echocardiography or computed tomography. Surgical treatment involved isolated excision of the tumor or combined with valve repair or replacement in case of valvular involvement. Hospital mortality was absent. CONCLUSION: Successful surgical treatment implies urgency, optimal exposition under hypothermic perfusion and pharmaco-cold cardioplegia, simple excision of the tumors and correction of comorbidities if it is necessary.
Subject(s)
Cardiac Surgical Procedures , Heart Neoplasms , Heart Valves , Neoplasms, Fibroepithelial , Papillary Muscles , Cardiac Surgical Procedures/adverse effects , Cardiac Surgical Procedures/methods , Dissection/methods , Echocardiography, Transesophageal/methods , Female , Heart Arrest, Induced/methods , Heart Neoplasms/pathology , Heart Neoplasms/surgery , Heart Valves/diagnostic imaging , Heart Valves/pathology , Heart Valves/surgery , Humans , Male , Middle Aged , Neoplasms, Fibroepithelial/pathology , Neoplasms, Fibroepithelial/surgery , Outcome and Process Assessment, Health Care , Papillary Muscles/diagnostic imaging , Papillary Muscles/pathology , Papillary Muscles/surgery , Russia , Time-to-Treatment , Tomography, X-Ray Computed/methodsABSTRACT
AIM: to study changes in the expression of angio- and vasculogenesis markers in colorectal adenocarcinoma metastases to the liver during combined cytotoxic and targeted anti-VEGF therapy versus cytotoxic monotherapy. SUBJECTS AND METHODS: Intraoperative samples from 96 patients with colorectal adenocarcinomas metastases to the liver were immunohistochemically examined. The investigation enrolled patients who had preoperatively received either combined FOLFOX6 cytotoxic therapy and targeted anti-VEGF therapy with bevacizumab or only FOLFOX6 therapy, as well as patients who had not received preoperative anti-tumor drug treatment. The expression of SDF1α, CXCR4, CXCR7, and VEGF-A was compared in these groups. Statistical significance was accepted at p<0.05. RESULTS: The expression of CXCR4 in the vessel endothelial cells was significantly less frequently detected in the patients who had received combined cytotoxic therapy and targeted anti-VEGF therapy as compared to those had not drug therapy. Comparing the patients treated with cytotoxic drugs with those who had not received anti-tumor therapy revealed similar results in the women. CXCR7 expression in the tumor cells and stromal cells from the metastatic foci was significantly more common in the group of male patients treated with cytotoxic drugs according to the FOLFOX6 regimen. The expression of SDF1α in the tumor cells was significantly more often observed in the male patients who had received combined cytotoxic therapy and targeted anti-VEGF therapy than in those who had not drug therapy. VEGF expression in the stromal cells was significantly less frequently seen in the patients who had received the combined therapy. CONCLUSION: Combined cytotoxic therapy and targeted anti-VEGF therapy for colorectal adenocarcinoma metastases to the liver leads to some suppression of the alternative pathway in the formation of new vessels, by reducing the expression of CXCR4 in the vessel endothelial cells and that of VEGF in the stromal cells from the metastatic foci. In men, this therapy simultaneously causes an increase in the expression of SDF1α in the tumor cells and in that of CXCR4 in the stroma. Preoperative FOLFOX6 therapy significantly increases the expression of CXCR7 in the tumor cells and stromal cells in the male patients, which may suggest that this pathway in vessel formation can be activated.
Subject(s)
Chemokine CXCL12/biosynthesis , Colorectal Neoplasms/genetics , Liver Neoplasms/genetics , Receptors, CXCR4/biosynthesis , Receptors, CXCR/biosynthesis , Vascular Endothelial Growth Factor A/biosynthesis , Adult , Aged , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Biomarkers, Tumor/biosynthesis , Biomarkers, Tumor/genetics , Chemokine CXCL12/genetics , Colorectal Neoplasms/drug therapy , Colorectal Neoplasms/pathology , Colorectal Neoplasms/radiotherapy , Female , Fluorouracil/administration & dosage , Gene Expression Regulation, Neoplastic/drug effects , Gene Expression Regulation, Neoplastic/radiation effects , Humans , Leucovorin/administration & dosage , Liver Neoplasms/drug therapy , Liver Neoplasms/radiotherapy , Liver Neoplasms/secondary , Male , Middle Aged , Neovascularization, Pathologic/genetics , Organoplatinum Compounds/administration & dosage , Receptors, CXCR/genetics , Receptors, CXCR4/genetics , Vascular Endothelial Growth Factor A/geneticsABSTRACT
A facultative methylotrophic bacterium, strain Lp-1, which was isolated from root nodules of lupine (Lupinus polyphyllus L.) on the medium with methanol as a carbon and energy source, exhibited high similarity of the 16S rRNA gene sequences to Delftia strains (94â99.9%). The cells of Delftia sp. Lp-1 were motile gram-negative rods dividing by binary fission. Predominant fatty acids were C16:0 (34.2%), C16:1ω9 (14.5%), and C18:1ω7c (17.3%). Phosphatidylethanolamine, phosphatidylcholine, and phosphatidylglycerol were the dominant phospholipids. Q8 was the major ubiquinone. Optimal growth occurred at 24â26°C and pH 7.1â7.3; growth was inhibited by 1% NaCl. The organism oxidized methanol with the classical methanol dehydrogenase and used the ribulose bisphosphate pathway of C1 metabolism. Analysis of translated amino acid sequence of the large subunit of the MxaF methanol dehydrogenase revealed 85.5â94% similarity to the sequences of such autotrophic methylotrophs of the class Alphaproteobacteria as Angulomicrobium, Starkeya, and Ancylobacter, indicating the possible acquisition of the mxaF gene via horizontal gene transfer. Delftia sp. Lp-1 (VKM B-3039, DSM 24446), the first methylotrophic member of the genus Delftia, was shown to be a plant symbiont, stimulating plant growth and morphogenesis, increasing the level of photosynthetic pigments and specific leaf weight. It possesses the nifH gene of nitrogen fixation, is capable of phosphate solubilization, synthesis of auxins and siderophores, and is antagonistic to plant pathogenic fungi and bacilli.
Subject(s)
Autotrophic Processes/physiology , Delftia , Lupinus/microbiology , Root Nodules, Plant/microbiology , Symbiosis/physiology , Delftia/classification , Delftia/genetics , Delftia/isolation & purification , Delftia/metabolismABSTRACT
The paper describes a case of parosteal lipoma of the temporal bone, by simultaneously involving the parotid salivary gland. Computed tomography performed in a 48-year-old man showed that in the area of the posterior edge of the glenoid fossa of the right temporal bone there was a massive (1.5×1.7×0.9-cm) exostosis extending down from the skull base. The exostosis was surrounded by a 3.5×3.6×5.3 soft tissue mass that was located in the projection of the right parotid salivary gland with a capsule and minor calcifications. Morphological examination determined a sessile exostosis-like mass in the area of the periosteum of the temporal bone. Foci of desmal and enchondral ossification (types III and IV according to the classification of Miller et al.) could be seen in the adjacent fatty tissue. The tumor underwent necrotic and dystrophic changes (Milgram's Stage 3). Temporal bone involvement was accompanied by osseous sialolipoma of the right parotid salivary gland. In this case, the fatty component accounted for 60-80% of salivary gland volume. Terminal secretory segments, ducts, and bone trabeculae with calcification foci and hematopoietic elements were uniformly distributed among the fatty tissue. None similar case has been found in the literature.
Subject(s)
Lipoma/pathology , Parotid Neoplasms/pathology , Skull Neoplasms/pathology , Humans , Lipoma/diagnostic imaging , Male , Middle Aged , Skull Neoplasms/diagnostic imaging , Temporal Bone/pathologyABSTRACT
UNLABELLED: To date, the modern Russian literature has not covered morphological studies of aortic aneurysm in Erdheim's idiopathic cystic medial necrosis on autopsy and surgical materials, by using immunohistochemical studies, and it has not estimated the magnitude of pathohistochemical changes in the aortic media either. AIM: to conduct a morphological examination of aortic aneurysm in Erdheim's idiopathic cystic medial necrosis, by using the material of pathology and forensic medical departments. MATERIAL AND METHODS: 41 surgical samples from patients with idiopathic cystic medial necrosis of the ascending aorta and autopsy samples from 17 sudden deaths from aortic rupture were examined. The aortic wall was histologically and histochemically studied. Immunohistochemical examination was done using antibodies to smooth muscle actin, collagens types I and III, elastin, CD3 (T lymphocytes), CD20 (B lymphocytes), CD45 (leukocyte common antigen), CD68 (macrophages), apoptotic marker p53, tumor necrosis factor-α (TNF-α), and intercellular adhesion molecule-1 (ICAM-1). RESULTS: Morphological examination showed lamellar unit destruction, fibrosis, medial necrosis, and elastic fiber fragmentation. These signs were assessed by their degree. The immunohistochemical examination of collagens types I and III determined fascicles of randomly positioned fibers. The multidirectional orientation of smooth muscle cells was confirmed by the expression of smooth muscle actin. There was an obvious expression of the apoptotic marker p53 in the smooth muscle cells of the aortic media and in the aortic adventitia. The expression of TNF-α was revealed in the cells of an inflammatory infiltrate in the aneurysm wall and that of ICAM-1 was found in the aortic endothelium, vasa vasorum, and in the cells of an inflammatory infiltrate in the media and adventitia. The paper proposes a design of postmortem and forensic medical diagnosis, which reflects the components of pathogenesis and tanatogenesis in Erdheim's idiopathic cystic medial necrosis and which allows ICD-10 diagnosis coding. CONCLUSION: The main histopathological signs of aortic aneurysm in Erdheim's idiopathic cystic medial necrosis were presented; structural changes in the primary components of the aortic wall were characterized; the cells of an inflammatory infiltrate were investigated; and the formulation of autopsy and forensic medical diagnoses was proposed.
Subject(s)
Aortic Aneurysm, Thoracic/pathology , Cysts/pathology , Actins/genetics , Actins/metabolism , Adolescent , Adult , Aged , Antigens, CD/genetics , Antigens, CD/metabolism , Antigens, Differentiation, Myelomonocytic/genetics , Antigens, Differentiation, Myelomonocytic/metabolism , Aortic Aneurysm, Thoracic/metabolism , Case-Control Studies , Cysts/metabolism , Death, Sudden , Female , Forensic Pathology , Humans , Intercellular Adhesion Molecule-1/genetics , Intercellular Adhesion Molecule-1/metabolism , Leukocyte Common Antigens/genetics , Leukocyte Common Antigens/metabolism , Male , Middle Aged , Myocytes, Smooth Muscle/metabolism , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism , Tumor Suppressor Protein p53/genetics , Tumor Suppressor Protein p53/metabolismABSTRACT
The results of analysis of the literature data were used to develop the forensic medical criteria for the assessment of the suitability of paraffin blocks containing the imbedded malignant tumours for the genetic identification of the tissues. The forensic medical criteria and the algorithm for the preliminary characteristic of the material of interest were proposed to avoid the potential errors. It is not recommended to use gastrointestinal carcinomas, breast tumours, and poorly differentiated ovarian tumours. Also unsuitable is the material formerly exposed to radio- and chemotherapeutic agents or paraffin blocks stored during more than 5-7 years. In the doubtful cases, immunohistochemical studies must be carried out to confirm microsatellite instability. Moreover, the tumour genotype and DNA composition from the patients' blood should be confirmed.
Subject(s)
Diagnostic Errors/prevention & control , Neoplasms , Paraffin Embedding , Specimen Handling , Forensic Genetics/methods , Genetic Testing/methods , Humans , Neoplasms/diagnosis , Neoplasms/genetics , Paraffin Embedding/methods , Paraffin Embedding/standards , Specimen Handling/methods , Specimen Handling/standardsABSTRACT
AIM: To analyze clinical-diagnostic and surgical aspects of cardiac valve solid lesions as well as long-term results of surgical treatment. MATERIAL AND METHODS: Clinical, diagnostic and surgical aspects of treatment of 51 patients with tumorous and pseudotumorous lesions of cardiac valves were analyzed. RESULTS AND DISCUSSION: Hospital complications were observed in 17.7% of patients. Mortality rate was 3.9%. 1- and 28-year overall survival was 100% and 94.1% respectively. Quality of life was good, satisfactory and unsatisfactory in 73.5%, 20.4% and 6.1% of cases respectively. CONCLUSION: Timely diagnostics of tumorous and pseudotumorous lesions of cardiac valves is very difficult but possible based on short history, positional dependence of symptoms, embolic events without rhythm disturbances. Additional instrumental methods including TTE, TEE, CT and MRI are necessary to define diagnosis. Intraoperative diagnostics and immediate histological survey are useful to determine volume of surgery in each case. Successful surgical treatment implies urgency, hypothermic perfusion and pharmaco-cold cardioplegia during operation.
Subject(s)
Cardiac Surgical Procedures , Embolism , Heart Neoplasms , Heart Valve Diseases , Adult , Cardiac Surgical Procedures/adverse effects , Cardiac Surgical Procedures/methods , Echocardiography, Transesophageal/methods , Embolism/diagnosis , Embolism/etiology , Female , Heart Neoplasms/classification , Heart Neoplasms/mortality , Heart Neoplasms/pathology , Heart Neoplasms/physiopathology , Heart Neoplasms/surgery , Heart Valve Diseases/mortality , Heart Valve Diseases/pathology , Heart Valve Diseases/physiopathology , Heart Valve Diseases/surgery , Humans , Intraoperative Care/methods , Magnetic Resonance Imaging, Cine/methods , Male , Middle Aged , Moscow , Patient Selection , Survival Analysis , Tomography, X-Ray Computed/methods , Treatment OutcomeABSTRACT
The paper describes a case of von Hippel--Lindau-related pancreatic neuroendocrine tumor and adrenal myelolipoma in a 44-year-old woman. The pancreatic tumor and a left retroperitoneal mass were removed in the women in July 2014 and May 2015. Histological examination of the pancreatic tumor revealed that the latter consisted of clear cells forming tubular and tubercular structures showing the expression of chromogranin A, synaptophysin, and cytokeratins 18 and 19 and a negative response to CD10 and RCC. The adrenal medullary mass presented as clear-cell alveolar structures with inclusions of adipose tissue mixed with erythroid, myeloid, and lymphoid cells. The clear-cell component of the adrenal gland expressed neuroendocrine markers with a negative response to cytokeratins, CD10, and RCC. Molecular genetic examination yielded a signal corresponding to two copies of the VHL gene. No deletions or amplifications of the gene were detected. Cases of von Hippel--Lindau disease concurrent with adrenal pheochromocytoma and myelolipoma and simultaneous pancreatic involvement were not found in the literature.
Subject(s)
Adrenal Gland Neoplasms/pathology , Myelolipoma/pathology , Neuroendocrine Tumors/pathology , von Hippel-Lindau Disease/pathology , Adrenal Gland Neoplasms/complications , Adrenal Gland Neoplasms/diagnosis , Adrenal Gland Neoplasms/genetics , Adult , Chromosome Aberrations , Female , Gene Expression Regulation, Neoplastic , Humans , Myelolipoma/complications , Myelolipoma/diagnosis , Myelolipoma/genetics , Neoplasm Proteins/biosynthesis , Neoplasm Proteins/genetics , Neuroendocrine Tumors/complications , Neuroendocrine Tumors/diagnosis , Neuroendocrine Tumors/genetics , Pancreatic Neoplasms/complications , Pancreatic Neoplasms/diagnosis , Pancreatic Neoplasms/genetics , Pancreatic Neoplasms/pathology , Pathology, Molecular , Pheochromocytoma/complications , Pheochromocytoma/diagnosis , Pheochromocytoma/genetics , Pheochromocytoma/pathology , von Hippel-Lindau Disease/complications , von Hippel-Lindau Disease/diagnosis , von Hippel-Lindau Disease/geneticsABSTRACT
AIM: to estimate the expression of p53 protein, effector caspases-3 and -7, and the antiapoptotic protein survivin in colorectal adenocarcinoma metastases to the liver in patients who have received preoperative cytotoxic and combined cytotoxic and target anti-VEGF therapies. SUBJECTS AND METHODS: Intraoperative samples from 122 patients with colorectal carcinoma metastases to the liver were immunohistologically examined. The investigation included patients who had received preoperative treatment with cytotoxic drugs, combined cytotoxic and targeted anti-VEGF therapy. A control group consisted of patients who had not received preoperative anti-tumor drug treatment. RESULTS: Expression of Caspase 3, including that of survivin, was significantly more frequently detected in the patients who had received combined cytotoxic and anti-VEGF therapy as compared to both those treated with only cytotoxic agents (p=0.00004) and the control group (p=0.0008) As compared to the latter, the women who had received cytotoxic therapy were found to have no survivin expression (p=0.015). Investigation of the expression of caspase-7 and p53 revealed no statistically significant differences between the three groups. CONCLUSION: Addition of bevacizumab to preoperative standard therapy regimens for colorectal adenocarcinoma metastases to the liver leads to activated apoptosis in tumor cells, by enhancing the expression of effector caspase 3. At the same time, standard cytotoxic chemotherapy regimens in women results in activated apoptosis, by decreasing the expression of the antiapoptotic protein survivin.
Subject(s)
Caspase 3/biosynthesis , Colorectal Neoplasms/drug therapy , Inhibitor of Apoptosis Proteins/biosynthesis , Liver Neoplasms/drug therapy , Adult , Apoptosis/drug effects , Bevacizumab/administration & dosage , Caspase 3/genetics , Colorectal Neoplasms/genetics , Colorectal Neoplasms/pathology , Female , Gene Expression Regulation, Neoplastic/drug effects , Humans , Inhibitor of Apoptosis Proteins/genetics , Liver Neoplasms/genetics , Liver Neoplasms/pathology , Liver Neoplasms/secondary , Male , Middle Aged , Preoperative Period , Survivin , Tumor Suppressor Protein p53/biosynthesis , Tumor Suppressor Protein p53/genetics , Vascular Endothelial Growth Factor A/antagonists & inhibitorsABSTRACT
OBJECTIVE: To study E-cadherin and ß-catenin expression in colorectal cancer (CRC) liver metastases in order to assess the impact of different drug therapy regimens on the adhesive properties of tumor cells. MATERIAL AND METHODS: Intraoperative metastatic CRC samples from patients who had received preoperative cytotoxic chemotherapy or combined cytotoxic and targeted anti-VEGF (vascular endothelial growth factor) therapy were immunohistochemically examined using antibodies to E-cadherin and ß-catenin. A comparison group consisted of patients who had not received drug therapy. RESULTS: Combined therapy with cytotoxic and anti-VEGF agents was shown to result in a significant increase in the number of cases of normal membrane localization of E-cadherin as compared with control (p = 0.00043) and cytotoxic therapy-alone (p = 0.01) groups. A comparison of ß-catenin levels in three patient groups revealed no significant differences, but addition of an anti-VEGF agent caused some decrease in the number of cases of abnormal nuclear localization of the protein as compared to both the control group and the cytotoxic therapy groups. The comparison of E-cadherin and ß-catenin localization in tumor cells showed that a combination of normal E-cadherin membrane localization and ß-catenin membrane-cytoplasmic expression prevailed in the combined therapy group compared to the control (p = 0.009) and cytotoxic therapy (p = 0.04) groups. CONCLUSION: The addition of a targeted anti-VEGF agent to the drug therapy of metastatic CRC has a positive impact on the cadherin-catenin complex, leading to increased intercellular contacts and suppressed ß-catenin functioning as a transcription factor that enhances tumor cell proliferation.